EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million, as an Egyptian public shareholder company operating according to the Investment Law (No. 43/1974 modified by Law No. 32/1977). EIPICO started production in 1985 as the Leading Company in Egypt and in the Middle East and North Africa (MENA) Region, to produce pharmaceutical products according to Good Manufacturing Practice (G.M.P.) regulations, with the aim of providing local and international markets with high quality products at affordable prices.